| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Vittorio Ricci | |
| Marco Romano | |||
| Raffaele Zarrilli | |||
| P2860 | cites work | Helicobacter pylori persistence: biology and disease | Q24618823 |
| Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis | Q28166328 | ||
| Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report | Q28203195 | ||
| Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin | Q28273716 | ||
| Oncogenic mechanisms of the Helicobacter pylori CagA protein | Q28280246 | ||
| Helicobacter pylori infection induces gastric cancer in mongolian gerbils | Q28280923 | ||
| Helicobacter pylori infection and the development of gastric cancer | Q29615341 | ||
| Helicobacter pylori infection and the risk of gastric carcinoma | Q29618446 | ||
| Helicobacter pylori and gastrointestinal tract adenocarcinomas | Q29618635 | ||
| The translation of Helicobacter pylori basic research to patient care | Q30439180 | ||
| Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells | Q30476325 | ||
| Intracellular Helicobacter pylori in gastric epithelial progenitors | Q30856815 | ||
| Helicobacter pylori virulence and genetic geography | Q33639332 | ||
| Tyrosine-phosphorylated bacterial proteins: Trojan horses for the host cell | Q33843502 | ||
| NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein | Q33878876 | ||
| Activation of beta-catenin by carcinogenic Helicobacter pylori | Q33906825 | ||
| Recent developments in the epidemiology of Helicobacter pylori | Q34059121 | ||
| Molecular response of gastric epithelial cells to Helicobacter pylori-induced cell damage. | Q34156229 | ||
| Targeting cyclooxygenase-2 in human neoplasia: rationale and promise | Q34287766 | ||
| Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island | Q34359740 | ||
| Helicobacter infection and gastric neoplasia | Q34477682 | ||
| Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia | Q34546045 | ||
| The future of gastric cancer prevention | Q34546719 | ||
| Long term follow up of patients treated for Helicobacter pylori infection. | Q34619683 | ||
| Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation | Q34621164 | ||
| Alteration of histological gastritis after cure of Helicobacter pylori infection | Q34975851 | ||
| Epigenetics in cancer: implications for early detection and prevention | Q35021339 | ||
| Helicobacter pylori promote gastric cancer cells invasion through a NF-kappaB and COX-2-mediated pathway | Q35045577 | ||
| Helicobacter pylori virulence factors and the host immune response: implications for therapeutic vaccination | Q35089516 | ||
| Developing inhibitors of the epidermal growth factor receptor for cancer treatment. | Q35157038 | ||
| Gastric cell apoptosis and H. pylori: has the main function of VacA finally been identified? | Q35295796 | ||
| The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population | Q35597205 | ||
| Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention | Q36002131 | ||
| Helicobacter pylori VacA, a paradigm for toxin multifunctionality | Q36066993 | ||
| The role of genome diversity and immune evasion in persistent infection with Helicobacter pylori. | Q36159561 | ||
| Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique | Q36243482 | ||
| Tumor inflammatory angiogenesis and its chemoprevention | Q36328565 | ||
| Modification of Helicobacter pylori outer membrane protein expression during experimental infection of rhesus macaques | Q36604828 | ||
| Helicobacter pylori upregulates expression of epidermal growth factor-related peptides, but inhibits their proliferative effect in MKN 28 gastric mucosal cells. | Q39802405 | ||
| Helicobacter pylori CagA transfection of gastric epithelial cells induces interleukin-8. | Q40338115 | ||
| The effect of ascorbic acid on Helicobacter pylori induced cyclooxygenase 2 expression and prostaglandin E2 production by gastric epithelial cells in vitro. | Q40462112 | ||
| The Helicobacter pylori VacA cytotoxin activates RBL-2H3 cells by inducing cytosolic calcium oscillations. | Q40469159 | ||
| Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. | Q40527352 | ||
| Helicobacter pylori gamma-glutamyltranspeptidase upregulates COX-2 and EGF-related peptide expression in human gastric cells | Q40592348 | ||
| Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. | Q40643877 | ||
| Helicobacter pylori-stimulated EGF receptor transactivation requires metalloprotease cleavage of HB-EGF. | Q40720495 | ||
| cag+ Helicobacter pylori induce transactivation of the epidermal growth factor receptor in AGS gastric epithelial cells | Q40774288 | ||
| Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials | Q41018165 | ||
| Helicobacter pylori induces apoptosis of human monocytes but not monocyte-derived dendritic cells: role of the cag pathogenicity island | Q41195733 | ||
| The time to eradicate gastric cancer is now | Q41824540 | ||
| Effects of growth factors and receptor blockade on gastrointestinal cancer | Q42239344 | ||
| Helicobacter pylori but not high salt induces gastric intraepithelial neoplasia in B6129 mice. | Q42487210 | ||
| Chemoprevention of gastric cancer by celecoxib in rats. | Q43003893 | ||
| Total antioxidant potential of fruit and vegetables and risk of gastric cancer | Q43528269 | ||
| A novel apoptosis-inducing protein from Helicobacter pylori. | Q44272819 | ||
| Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma | Q44588813 | ||
| Helicobacter pylori strain-selective induction of matrix metalloproteinase-7 in vitro and within gastric mucosa | Q44601444 | ||
| Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial | Q44727161 | ||
| Green tea: prevention and treatment of cancer by nutraceuticals | Q45068920 | ||
| Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity | Q47661604 | ||
| Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer | Q48019587 | ||
| Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. | Q53362709 | ||
| Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy | Q57112358 | ||
| Geographic distribution of vacA allelic types of Helicobacter pylori | Q59182779 | ||
| Vascular endothelial growth factor and neo-angiogenesis inH. pylori gastritis in humans | Q62992428 | ||
| Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms | Q73351351 | ||
| Helicobacter pylori up-regulates cyclooxygenase-2 mRNA expression and prostaglandin E2 synthesis in MKN 28 gastric mucosal cells in vitro | Q77458328 | ||
| Nutrient intake patterns and gastric cancer risk: a case-control study in Belgium | Q77493481 | ||
| Cutting edge: VacA, a vacuolating cytotoxin of Helicobacter pylori, directly activates mast cells for migration and production of proinflammatory cytokines | Q77743650 | ||
| Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis | Q77813241 | ||
| Gastric cancer originating from bone marrow-derived cells | Q81067451 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Helicobacter pylori | Q180556 |
| carcinogenesis | Q1637543 | ||
| P304 | page(s) | 622-632 | |
| P577 | publication date | 2006-11-01 | |
| P1433 | published in | Nature Reviews Gastroenterology & Hepatology | Q2108255 |
| P1476 | title | Mechanisms of disease: Helicobacter pylori-related gastric carcinogenesis--implications for chemoprevention | |
| P478 | volume | 3 |
| Q38614720 | A Comprehensive Review on Pharmacotherapeutics of Three Phytochemicals, Curcumin, Quercetin, and Allicin, in the Treatment of Gastric Cancer. |
| Q37054346 | Adenoviral gene therapy in gastric cancer: a review |
| Q41125099 | Anti-Inflammatory Effects of Capsaicin and Piperine on Helicobacter pylori-Induced Chronic Gastritis in Mongolian Gerbils. |
| Q38191565 | Eradication of Helicobacter pylori infection: which regimen first? |
| Q64092275 | Genetic diversity and amino acid sequence polymorphism in Helicobacter pylori CagL hypervariable motif and its association with virulence markers and gastroduodenal diseases |
| Q56347632 | Helicobacter pylori and extragastric diseases: A review |
| Q27022681 | Helicobacter pylori gamma-glutamyl transpeptidase and its pathogenic role |
| Q28484805 | Helicobacter pylori gamma-glutamyltranspeptidase induces cell cycle arrest at the G1-S phase transition |
| Q35044215 | Helicobacter pylori infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea. |
| Q39937536 | Helicobacter pylori protein HP0175 transactivates epidermal growth factor receptor through TLR4 in gastric epithelial cells |
| Q38746333 | Inflammatory and Apoptotic Regulatory Activity of Tanshinone IIA in Helicobacter pylori-Infected Cells |
| Q38062446 | Intestinal microbiota, probiotics and human gastrointestinal cancers |
| Q37304261 | Methylation of PTCH1a gene in a subset of gastric cancers |
| Q42709546 | Molecular cross-talk between Helicobacter pylori and human gastric mucosa |
| Q58579617 | Peptide Hp(2-20) accelerates healing of TNBS-induced colitis in the rat |
| Q40608496 | Pharmacokinetics and Safety of Triple Therapy with Vonoprazan, Amoxicillin, and Clarithromycin or Metronidazole: A Phase 1, Open-Label, Randomized, Crossover Study |
| Q26825488 | Probiotics against neoplastic transformation of gastric mucosa: effects on cell proliferation and polyamine metabolism |
| Q90217026 | Reevaluation of the Efficacy of First Line Regimen for Helicobacter pylori |
| Q26744715 | Relationship between VacA Toxin and Host Cell Autophagy in Helicobacter pylori Infection of the Human Stomach: A Few Answers, Many Questions |
| Q47145324 | The effects of starter microbiota and the early life feeding of medium chain triglycerides on the gastric transcriptome profile of 2- or 3-week-old cesarean delivered piglets. |
| Q27657855 | Three-Dimensional Structure of N-Terminal Domain of DnaB Helicase and Helicase-Primase Interactions in Helicobacter pylori |
| Q35234702 | Use of larvae of the wax moth Galleria mellonella as an in vivo model to study the virulence of Helicobacter pylori |
| Q34123743 | Variations in Helicobacter pylori cytotoxin-associated genes and their influence in progression to gastric cancer: implications for prevention |
| Q92000023 | Variations in cag pathogenicity island genes of Helicobacter pylori from Latin American groups may influence neoplastic progression to gastric cancer |
Search more.